UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12B-25

                        Commission File Number: 01-28911

                           NOTIFICATION OF LATE FILING

                                   (Check one)

            |X| Form 10-K      |_| Form 11-K  |_| Form 10-Q |_| Form N-SAR
            |_| Form 10-KSB

                       For Period Ended: September 30, 2004

                       [ ] Transition Report on Form 10-K
                       [ ] Transition Report on Form 20-F
                       [ ] Transition Report on Form 11-K
                       [ ] Transition Report on Form 10-Q
                       [ ] Transition Report on Form N-SAR

                      For the Transition Period Ended: N/A

If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:

                                     PART I
                             REGISTRANT INFORMATION

                      NATIONAL HEALTHCARE TECHNOLOGY, INC.
                             FULL NAME OF REGISTRANT


                            FORMER NAME IF APPLICABLE

                          20700 Ventura Blvd. Suite 227
            Address of principal executive offices(Street and Number)

                            Woodland Hills, CA 91367
                            CITY, STATE AND ZIP CODE

                                     PART II
                             RULES 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check appropriate box.) [ ] Yes [ ] No

[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense.

[X] (b) The subject annual report, semi-annual report, transition report on Form
10-K, 20-F, 11-K or N-SAR, or portion thereof, will be filed on or before the
15th calendar day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof, will be filed on
or before the fifth calendar day following the prescribed due date.





[ ] The accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.

                                    PART III
                                    NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.

The Registrant's annual report on Form 10-KSB will be filed on or before the
fifteenth calendar following the prescribed due date. The reason for the delay
is that the Registrant is waiting for certain information from a third party.

                                     PART IV
                                OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
notification:

CHARLES SMITH (818) 887-7201
--------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or such shorter period that the registrant
was required to file such report(s) been filed? If answer is no, identify
report(s). [x] Yes [ ] No

(3) Is it anticipated that any significant change in results of operation for
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof? [ ]
Yes [x] No

If so, attach an explanation of anticipated change, both narratively and
quantitatively, and if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

                      NATIONAL HEALTHCARE TECHNOLOGY, INC.
--------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.


Date December 29, 2004                          By: /s/ Charles Smith
                                                    --------------------------
                                                    Charles Smith, CFO



Instruction: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

Intention misstatements or omissions of fact constitute Federal criminal
violations. (See 18 U.S.C. 1001)